A cell viability assay was conducted to investigate effect of RP with different radioisotopes. NCI-N87 cells overexpressing the HER2 protein were seeded at a density of 104 cells/well and incubated for 48 h after treatments. The cells were exposed to three types of drugs: trastuzumab, 177Lu-DOTA-trastuzumab, and 225Ac-DOTA-trastuzumab.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chi
Contact Chi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack